Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

47 Results Found

Judge: HHS has authority to preapprove implementation of 340B ‘rebate models’

A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate models” before they can be implemented, which the department has not yet done for any of the models pursued by the plaintiff drug companies. 

AHA files brief defending South Dakota’s 340B contract pharmacy law

The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.

AHA comments to HHS on 340B drug rebate models

The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models.

AHA shares concerns on data exchange provision under drug price negotiation program

The AHA May 1 expressed concerns to the Centers for Medicare & Medicaid Services about the payment process established under the Medicare Drug Price Negotiation Program, explaining ways it undermines the purpose of the 340B Drug Pricing Program.

AHA files brief in defense of Nebraska’s 340B contract pharmacy law

The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state’s 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.

Cassidy releases report calling for reforms to 340B program

Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., April 24 released a report detailing findings from an investigation into how covered entities use and generate revenue from the 340B Drug Pricing Program.

AHA files briefs in defense of Louisiana's 340B contract pharmacy law

The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.

Minnesota court dismisses PhRMA lawsuit challenging state 340B law

A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state’s law protecting 340B pricing for contract pharmacy arrangements.

White House issues executive order on drug pricing

The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.

HHS files brief in 340B rebate model case

The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief filed March 17 with the United States District Court for the District of Columbia.